Brian Cunningham, CCIL Research Program Leader, is developing new technology to detect molecules and viruses from bodily fluids. The goal is to use light energy from optical emitters and a photonic crystal surface to bridge the gap between “macro” and “nano” worlds.
This innovation can help researchers detect and analyze biomarkers for cancer and viruses like COVID-19 at an observable scale.